Table 2 Comparision of the incidence of lipidemia between breast cancer patients and control group
Parameter | Breast cancer (n = 1054) | Control group (n = 2483) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TC (Mean ± SD, mmol/L) | TG (Mean ± SD, mmol/L) | HDL-C (Mean ± SD, mmol/L) | LDL-C (Mean ± SD, mmol/L) | Dyslipidemia (n, %) | TC (Mean ± SD, mmol/L) | TG (Mean ± SD, mmol/L) | HDL-C (Mean ± SD, mmol/L) | LDL-C (Mean ± SD, mmol/L) | Dyslipidemia (n, %) | ||
Total | 4.47 ± 0.93** | 1.27 ± 1.02* | 1.43 ± 0.36** | 2.80 ± 0.81** | 453(42.98)** | 5.01 ± 0.95 | 1.33 ± 0.86 | 1.48 ± 0.32 | 3.19 ± 0.87 | 1447(58.28) | |
Age stratification (years) | 20–39 | 4.04 ± 0.83* | 0.95 ± 0.54 | 1.45 ± 0.34 | 2.43 ± 0.73 | 33(25.58) | 4.27 ± 0.70 | 0.94 ± 0.44 | 1.47 ± 0.29 | 2.52 ± 0.65 | 78(22.41) |
40–49 | 4.32 ± 0.85** | 1.14 ± 0.67* | 1.43 ± 0.33* | 2.69 ± 0.76** | 150(34.88)** | 4.84 ± 0.84 | 1.25 ± 0.90 | 1.49 ± 0.32 | 3.03 ± 0.78 | 447(49.72) | |
50–59 | 4.67 ± 1.02** | 1.45 ± 1.53 | 1.42 ± 0.40** | 2.94 ± 0.84** | 149(52.84)** | 5.34 ± 0.92 | 1.44 ± 0.88 | 1.51 ± 0.35 | 3.47 ± 0.86 | 540(74.07) | |
≥60 | 4.78 ± 0.88** | 1.47 ± 0.91 | 1.45 ± 0.39 | 3.04 ± 0.79** | 121(56.81)** | 5.34 ± 0.95 | 1.59 ± 0.84 | 1.44 ± 0.31 | 3.51 ± 0.87 | 382(75.35) | |